The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of ailments affecting the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved about 800 older men with low testosterone and symptoms associated with this affliction, such anti aging supplement (Full Article) as sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.

The recent contradictory findings on testosterone treatment prompted Patel and his team to run a big systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the USA have problems with low testosterone, which happens when the body doesn't make enough hormones because of a problem with the testicles or pituitary gland. This clarifies clear aging, a person's unexpected weight gain and loss of energy.

And many women have a knee-jerk suspicion that any hormone treatment can raise their risk of breast cancer. However, clinical studies show that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will likely remain the status quo for a while, given the prohibitive cost of conducting the long-term safety studies needed to acquire completer FDA acceptance.